• Акилов Х.А., Ибадов Р.А., Хамраева Г.Ш., Ибрагимов С.Х.
  1–Центр развития профессиональной квалификации медицинских работников, Республика Узбекистан, г. Ташкент; 2–Республиканский специализированный научно–практический медицинский центр хирургии име-ни академика В.Вахидова, Республика Узбекистан, г. Ташкент

Abstract

В декабре 2019 года новая коронавирусная инфекция, получившая название SARS-CoV-2 (COVID-19), вызвала серию острых атипичных респираторных заболеваний в Ухане, провинция Хубэй, Китай. Вирус передается от человека к человеку и вызвал пандемию во всем мире. Разработка таргетной терапии, основанной на патофизиологии поражения легочной ткани при COVID-19 продолжает оставаться первостепенной задачей многих исследований. Эпидемиологические исследования показали, что пожилые пациенты более восприимчивы к тяжелым заболеваниям, а у детей отмечается более легкие симптомы. В статье рассмотрены текущие знания по патофизиологии и диагностике COVID-19.

Keywords

коронавирусная инфекция COVID-19, патофизиология, диагностика, обзор литературы.

Literature

Arabi Y.M., Balkhy H.H., Hayden F.G., Bouchama A., Luke T., Baillie J.K., et al. (2017). Middle East Respiratory Syndrome. N Engl. J. Med. 376 (6), 584–594. 10.1056/NEJMsr1408795 

Ai T, Yang Z, Hou H, et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. 2020; Radiology. 2020

Bowles L., Platton S., Yartey N. Lupus anticoagulant and abnormal coagulation tests in patients with COVID-19. N. Engl. J. Med. 2020 doi: 10.1056/NEJMc2013656

Channappanavar R., Perlman S. Pathogenic human coronavirus infections cause and consequences of cytokine storm and immunopathology. Semin. Immunopathol. 2017;39(5):529–539.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–13.

Corman V.M., Landt O., Kaiser M. Detection of 2019 novel coronavirus by real-time RT-PCR. Euro Surveill. 2020;25(3).

Fox SE, Akmatbekov A, Harbert JL, Li G, Quincy Brown J, Vander Heide RS. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans. Lancet Respir Med. 2020 Jul;8(7):681-686.

Gavriilaki E, Brodsky RA. Severe COVID-19 infection and thrombotic microangiopathy: success does not come easily. Br J Haematol. 2020 Jun;189(6):e227-e230. doi: 10.1111/bjh.16783. Epub 2020 May 23. PMID: 32369610

Glas G.J., Van Der Sluijs K.F., Schultz M.J. Bronchoalveolar hemostasis in lung injury and acute respiratory distress syndrome. J. Thromb. haemost. 2013;11:17–25.

Grasselli G, Pesenti A, Cecconi M. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. JAMA. 2020. https://doi.org/10.1001/jama.2020.4031

Hui D.S., Azhar E., Madani T.A. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-The latest 2019 novel coronavirus outbreak in Wuhan, China. Int. J. Infect. Dis. 2020;91:264–266

Huang C., Wang Y., Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.

Ish P., Malhotra N., Agrawal S. Relative lymphocytosis in COVID-19-a ray of hope. Adv. Respir. Med. 2020;86(4).

Kasinathan G, Sathar J. Haematological manifestations, mechanisms of thrombosis and anti-coagulation in COVID-19 disease: A review. Ann Med Surg (Lond). 2020;56:173-177. Published 2020 Jun 30. doi:10.1016/j.amsu.2020.06.035

Kenny JES, Canepa CM. An illustrated guide to the chest CT in COVID. 2020; https://pulmccm.org/uncategorized/an-illustrated-guide-to-the-chest-ct-in-covid-19/ PulmCCM. 2020

Jin Y, Cai L, Cheng Z, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. 2020;7:16.

Jose RJ, Manuel A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respir Med. 2020 Jun;8(6):e46-e47. doi: 10.1016/S2213-2600(20)30216-2. Epub 2020 Apr 27. PMID: 32353251; PMCID: PMC7185942

Levi M., van der Poll T. Coagulation and sepsis. Thromb. Res. 2017;149:38-44.

Li D., Jin M., Bao P.T. Clinical characteristics and results of semen tests among men with coronavirus disease 2019. JAMA Netw. Open. 2020;3(5).

Lillicrap D. Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia. J. Thromb. Haemostasis. 2020;18(4):786-787

Lippi G., Plebani M. The critical role of laboratory medicine during coronavirus disease 2019 and other viral outbreaks. Clin. Chem. Lab. Med. 2020.

McGonagle D, O'Donnell JS, Sharif K, Emery P, Bridgewood C. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol. 2020 Jul;2(7):e437-e445.

Novel Coronavirus (2019-nCoV) situation reports. Available: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. [cited 15 Mar 2020].

Ong S.W., Tan Y.K., Chia P.Y. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. J. Am. Med. Assoc. 2020 (Epub ahead of print).

Qi Yang et al. Corresponding pathological changes are exudation in the alveolar cavity with partial filling of air cavity, mainly from serous and fibrinous exudates, alveolar septal vascular congestion and edema. Eur J Radiol. 2020 Jun; 127: 109008.

Sanders J.M., Monogue M.L., Jodlowski T.Z. Pharmacologic treatments for coronavirus disease 2019. J. Am. Med. Assoc. 2020;323(18):1824–1836.

Tang N., Bai H., Chen X. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J. Thromb. Haemostasis. 2020 doi: 10.1111/jth.14817.

Velavan T.P., Meyer C.G. Mild versus severe COVID-19:laboratory markers. Int. J. Infect. Dis. 2020

Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020.

WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020.

Wong HYF, Lam HYS, Fong AH, et al. Frequency and distribution of chest radiographic findings in COVID-19 positive patients. Radiology. 2020; 2020

Xu P., Zhou Q., Xu J. Mechanism of thrombocytopenia in COVID-19 patients. Ann. Hematol. 2020 (Epub ahead of print).

Yang X, Yu Y, Xu J, Shu H, J ’an X, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020. https://doi.org/10.1016/S2213-2600(20)30079-5

Zhang C., Wu J., Li J.W. The cytokine release syndrome (CRS) of severe COVID-19 and interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality. Int. J. Antimicrob. Agents. 2020:105954.

Zhang Y., Xiao Y., Zhang S. Coagulopathy and antiphospholipid antibodies in patients with COVID-19. N. Engl. J. Med. 2020 doi: 10.1056/NEJMc2007575

Zhu N., Zhang D., Wang W. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 2020;382(8):727-733